Exjade (deferasirox)

**Product type:** Human Prescription Drug

**Active ingredient:** DEFERASIROX

**Strength:** 125 mg/1

**Dosage form:** Tablet, For Suspension

**Route:** Oral

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** NDA (NDA021882)

**Pharmacologic class:** Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]